Molecular Dynamics studies of Long Neurotoxins against nAChR provide key insights towards design of therapeutic peptides for Dyskinesia
Shivam Pandit, Gargi Saha, J. D., H.G. Nagendra
The paper designs peptides targeting nAChR using molecular docking and dynamics to develop therapeutic options for Dyskinesia, showing a novel peptide has better binding affinity than a full toxin.
bioRxiv · May 22, 2023 · PreprintBioinformatics